Acadia Pharmaceuticals (ACAD) Free Cash Flow (2010 - 2026)
Acadia Pharmaceuticals (ACAD) reported Free Cash Flow of $95.69 million for Q2 2026, up 50.3% from $63.66 million a year earlier and up 232.6% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Free Cash Flow (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Acadia Pharmaceuticals' Free Cash Flow came in at $145.63 million, down 22.2% year-over-year; for FY2025, it came in at $105.15 million, down 33.1% from FY2024.
- By year, Free Cash Flow came in at $157.2 million in FY2024 (+844.0%), $16.65 million in FY2023, -$114.04 million in FY2022 and -$126.78 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Free Cash Flow in data going back to Q3 2010.
- Year over year, Free Cash Flow gained in four of the last six quarters, with growth averaging 30.0%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $28.77 million (Q1 2026), -$52.74 million (Q4 2025) and $73.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.56 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Acadia Pharmaceuticals | 3.47 Bn | -4.91 Mn | 279.64 Mn | 95.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.69 Mn |
| Mar 31, 2026 | 28.77 Mn |
| Dec 31, 2025 | -52.74 Mn |
| Sep 30, 2025 | 73.90 Mn |
| Jun 30, 2025 | 63.66 Mn |
| Mar 31, 2025 | 20.32 Mn |
| Dec 31, 2024 | 39.93 Mn |
| Sep 30, 2024 | 63.18 Mn |
| Jun 30, 2024 | 25.01 Mn |
| Mar 31, 2024 | 29.08 Mn |
| Dec 31, 2023 | 85.39 Mn |
| Sep 30, 2023 | -58.96 Mn |
| Jun 30, 2023 | 8.20 Mn |
| Mar 31, 2023 | -17.93 Mn |
| Dec 31, 2022 | -23.85 Mn |
| Sep 30, 2022 | -727,000.00 |
| Jun 30, 2022 | -13.13 Mn |
| Mar 31, 2022 | -76.33 Mn |
| Dec 31, 2021 | -23.12 Mn |
| Sep 30, 2021 | -17.06 Mn |
API Access
Acadia Pharmaceuticals Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();